Phase 3 Sarcopenia Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Role of Nutritional Intervention for the Treatment of Sarcopenia in Cirrhotic Patients with Refractory Ascites Candidate to Transjugular Intrahepatic Portosystemic Shunt Placement and Identification of Prognostic Factors Related to Clinical Outcome
Liver CirrhosisSarcopenia in Liver CirrhosisRefractory Ascites in Patients with Cirrhosis
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies72 enrolled2 locationsNCT06814626
Recruiting
Phase 3
Effect of Ketosteril on Sarcopenia in Patients With Chronic Kidney Disease
SarcopeniaChronic Kidney Disease
Huashan Hospital58 enrolled1 locationNCT06329622
Not Yet Recruiting
Phase 3
A novel development of liver-targeted androgen therapy for sarcopenia and synergistic benefit of resistance training in elderly
Sarcopenia
UNSW Sydney212 enrolled1 locationACTRN12619001408178
Recruiting
Phase 2Phase 3
Effect of HMB and vitamin D supplementation on osteosarcopenia in older persons
Osteosarcopenia
Western Health88 enrolled1 locationACTRN12619000636156